טוען...
The impact of antiviral therapy on hepatocellular carcinoma epidemiology
The development of nucleos(t)ide analogs and direct antiviral agents has revolutionized the management of chronic infection with HBV and HCV, respectively. These regimens allow to expand treatment to virtually all infected, including those with poor hepatic reserve and those with severe comorbiditie...
שמור ב:
| הוצא לאור ב: | Hepat Oncol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Medicine Ltd
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168041/ https://ncbi.nlm.nih.gov/pubmed/30302194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2017-0024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|